AstraZeneca Shocker Reminds Investors Miracle Drugs Are No Remedy for Risk

Jul 27, 2017 | Bad Credit Loans, Business Lending, Business Loans, Capital, Finance, Non-Bank Loans, Working Capital

Chasing exciting new developments in medicine can be a very expensive endeavor. Such is the takeaway from AstraZeneca’s announcement that a hotly anticipated clinical trial didn’t meet expectations.